Pfizer

COVID-19

US panel endorses widespread use of Pfizer COVID-19 vaccine

A U.S. government advisory panel endorsed widespread use of Pfizer’s coronavirus vaccine Thursday, putting the country just one step away from launching an epic vaccination campaign against the outbreak that has killed close to 300,000 Americans. Shots could begin within days, depending on how quickly the Food and Drug Administration signs off, as expected, on

COVID-19

Americans face new COVID-19 restrictions after Thanksgiving

Americans returning from Thanksgiving break faced strict new coronavirus measures around the country Monday as health officials brace for a disastrous worsening of the nationwide surge because of holiday gatherings over the long weekend. Los Angeles County imposed a stay-at-home order for its 10 million residents, and Santa Clara County, in the heart of Silicon

COVID-19

Keep the mask: A vaccine won’t end the US crisis right away

Don’t even think of putting the mask away anytime soon. Despite the expected arrival of COVID-19 vaccines in just a few weeks, it could take several months — probably well into 2021 — before things get back to something close to normal in the U.S. and Americans can once again go to the movies, cheer

COVID-19

2nd virus vaccine shows striking success in US tests

A second experimental COVID-19 vaccine — this one from Moderna Inc. — yielded extraordinarily strong early results Monday, another badly needed dose of hope as the pandemic enters a terrible new phase. Moderna said its vaccine appears to be 94.5% effective, according to preliminary data from an ongoing study. A week ago, competitor Pfizer Inc.

COVID-19

Trump, still not conceding defeat, trumpets vaccine progress

Gliding over significant challenges still to come, President Donald Trump on Friday offered a rosy update on the race for a vaccine for the resurgent coronavirus as he delivered his first public remarks since his defeat by President-elect Joe Biden. He still did not concede the election. Trump spoke from the the Rose Garden as

COVID-19

Pfizer says COVID-19 vaccine is looking 90% effective

Pfizer Inc. said Monday that its COVID-19 vaccine may be a remarkable 90% effective, based on early and incomplete test results that nevertheless brought a big burst of optimism to a world desperate for the means to finally bring the catastrophic outbreak under control. The announcement came less than a week after an election seen

Scroll to Top